Gryphon Analytics Copyright 2012-2017

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Google+ Icon

December 10, 2019

The purpose of this study is to provide corporate finance professionals, managers, and investors, an overview of valuation fundamentals employed in today’s pharmaceutical and biotech communities. These findings are relevant to understanding the values assigned by parti...

September 16, 2019

The purpose of the study is to provide corporate finance professionals, operators, and investors, an overview of the fundamental trends impacting venture capital investment in the healthcare and life sciences communities.

This study is part of Gryphon Analytics’ public...

February 21, 2017

In this 2017 Specialty Pharmacy Report, we highlight today’s growth areas and opportunities, with an aim to provide insight into current trends and business drivers. This report explores the shifts taking place within the industry to enable stakeholders to formulate be...

September 1, 2016

Dominant longer-term investment themes for healthcare
investors will be true innovation or cost-control.
Successful business models will increasingly offer a
differentiated ability to either 1) deliver clinically superior
outcomes or 2) take costs out of the system. Th...

August 12, 2016

The passage of the Patient Protection and Affordable Care Act (PPACA) in March 2010 and continued cost pressures may drive a radical reshaping of the healthcare market over the next decade. The market will evolve around the provisions in the legislation as changes to i...

July 15, 2016

US health services deal volume in Q2 2016 increased by approximately 8% from Q1 2016and 16% on a year-over-year basis. 239 health services deals were announced for $16.1billion in deal value during Q2 2016.The Long-Term Care sub-sector contributed approximately 36% (87...

November 25, 2015

The growth of pharma industries has slowed in recent years because of various reasons such as patent expiries, generic competition, drying pipelines, and increasingly stringent regulatory guidelines. Many blockbuster drugs will loose their exclusivity in next 5 years....

November 1, 2014

China is currently undergoing unprecedented political, demographic, and economic change. With a government stated goal of providing universal healthcare access to every one of its 1.3 billion people, China’s recent efforts to reform and improve the healthcare sector is...

October 24, 2014

In corporate development there are few investable and actionable certainties. Here today, we face one of the most significant certainties that operators and investors will encounter for
decades to come – the comprehensive redesign of the health services and life scienc...

May 1, 2013

In this 2015 Specialty Pharmacy Report, we highlight today’s growth areas and opportunities,with an aim to provide insight into current trends and business drivers.T his report explores the shifts taking place within the industry to enable stakeholders to formulate bet...

Please reload

Featured Reviews

U.S. Healthcare Outlook

October 24, 2014

1/2
Please reload

Development & Valuation
Healthcare & Life Sciences Outlook